Supernus Pharmaceuticals Inc banner

Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 49.91 USD -1.09% Market Closed
Market Cap: $2.9B

Wall Street
Price Targets

SUPN Price Targets Summary
Supernus Pharmaceuticals Inc

Wall Street analysts forecast SUPN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUPN is 62.56 USD with a low forecast of 55.55 USD and a high forecast of 68.25 USD.

Lowest
Price Target
55.55 USD
11% Upside
Average
Price Target
62.56 USD
25% Upside
Highest
Price Target
68.25 USD
37% Upside
Supernus Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

63% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
63% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 14 years the compound annual growth rate for Supernus Pharmaceuticals Inc's revenue is 63%. The projected CAGR for the next 3 years is 18%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SUPN's stock price target?
Price Target
62.56 USD

According to Wall Street analysts, the average 1-year price target for SUPN is 62.56 USD with a low forecast of 55.55 USD and a high forecast of 68.25 USD.

What is Supernus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
18%

For the last 14 years the compound annual growth rate for Supernus Pharmaceuticals Inc's revenue is 63%. The projected CAGR for the next 3 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett